BIOMARIN PHARMACEUTICAL INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
  • Biomarin Pharmaceutical Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $25M, a 69% increase year-over-year.
  • Biomarin Pharmaceutical Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $42.1M, a 419% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2023 was $20.9M, a 161% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2022 was $8.02M.
  • Biomarin Pharmaceutical Inc annual Income Tax Expense (Benefit) for 2021 was -$11.3M, a 98.8% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $42.1M $25M +$10.2M +69% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $31.9M $16.9M +$11M +186% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $20.9M -$1.05M +$16.3M +93.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $4.66M $1.29M -$3.46M -72.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $8.11M $14.8M +$7.58M +106% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $531K $5.91M -$7.48M -55.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $8.02M -$17.3M -$8.63M -99.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $16.6M $4.75M +$14.4M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.23M $7.19M +$5.97M +492% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$3.74M $13.4M +$7.53M +129% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$11.3M -$8.68M +$55.2M +86.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$66.5M -$9.67M +$836M +98.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 -$903M $1.22M +$14.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$917M $5.86M -$14.1M -70.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$903M -$63.9M -$39.1M -158% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$864M -$846M -$801M -1771% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$63.1M -$13.1M -$8.63M -193% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$54.5M $20M +$16.5M +468% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$71M -$24.8M +$14.9M +37.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$85.8M -$45.2M -$38.4M -566% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$47.4M -$4.46M +$7.93M +64% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$55.3M $3.52M +$10.2M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$65.5M -$39.7M -$146M -137% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $80.2M -$6.79M +$1.3M +16.1% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $78.9M -$12.4M -$3.67M -42.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $82.5M -$6.66M +$1.36M +17% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $81.2M $106M +$107M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$26.3M -$8.09M +$21.3M +72.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 -$47.6M -$8.71M +$155M +94.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$203M -$8.02M -$1.94M -32% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$201M -$1.45M -$25.8M -106% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$175M -$29.4M -$29.9M -6184% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$145M -$164M -$163M -29490% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $18.2M -$6.08M +$1.13M +15.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $17.1M $24.3M +$20.3M +500% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$3.21M $483K +$4.71M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$7.92M -$554K -$6.33M -110% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$1.59M -$7.2M -$10.7M -306% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $9.1M $4.06M +$1.45M +55.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $7.66M -$4.22M -$4.93M -700% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $12.6M $5.77M +$4.53M +365% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $8.05M $3.49M +$8.2M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$150K $2.62M -$303K -10.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $153K $704K +$7.11M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$6.96M $1.24M +$1.65M Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$8.61M -$4.71M -$4.68M -13756% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 -$3.93M $2.92M -$701K -19.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$3.23M -$6.4M -$4.33M -208% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $1.1M -$411K -$4.32M -111% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $5.41M -$34K -$4.8M -101% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $10.2M $3.62M +$10.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 -$459K -$2.08M +$220M +99.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 -$220M $3.9M +$2.85M +270% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 -$223M $4.76M +$4.13M +649% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 -$227M -$7.05M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 -$222M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $1.06M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $636K Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.